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ABSTRACT A plasmid-located fosfomycin resistance gene, fosA8, was identiﬁed
from a CTX-M-15-producing Escherichia coli isolate recovered from urine. Identiﬁca-
tion of this gene was obtained by whole-genome sequencing. It encoded FosA8,
which shares 79% and 78% amino acid identity with the most closely related FosA2
and FosA1 enzymes, respectively. The fosA8 gene was located on a transferable 50-kb
plasmid of IncN type encoding high-level resistance to fosfomycin. In silico analysis
and cloning experiments identiﬁed fosA8 analogues (99% identity) in the genome of
Leclercia decarboxylata, which is an enterobacterial species with natural resistance to
fosfomycin. This ﬁnding adds L. decarboxylata to the list of enterobacterial species
that are a reservoir of fosA-like genes which have been captured from the chromo-
some of a progenitor and are then acquired by E. coli.
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Fosfomycin is a phosphonic acid-derived antibiotic with a broad-spectrum bacteri-cidal activity used as a ﬁrst-line oral agent for uncomplicated urinary tract infections
(1). It is receiving renewed interest worldwide as an antibiotic that contributes to the
sparing of carbapenems in the treatment of infections due to extended-spectrum
-lactamase (ESBL)-producing isolates (2, 3). These ESBL producers are increasingly
reported worldwide, particularly in Escherichia coli (4). Therefore, surveillance studies
aiming to evaluate the spread and to identify the nature of the fosfomycin resistance
determinants are becoming of growing importance for preserving the efﬁcacy of that
antibiotic.
Chromosomally encoded fosfomycin resistance mechanisms in E. coli include re-
duced drug uptake due to mutations in the genes encoding GlpT and UhpT transport-
ers or mutations in the fosfomycin target which is the enzyme catalyzing the ﬁrst step
in peptidoglycan biosynthesis, namely, MurA. Reduced drug uptake remains the most
frequent fosfomycin resistance mechanism (1, 5). Transferable and plasmid-encoded
resistance mechanisms in E. coli are the FosA metalloenzymes, responsible for fosfo-
mycin inactivation by catalyzing the conjugation of glutathione to fosfomycin (1, 5).
FosA enzymes are Mn2 and K-dependent glutathione S-transferases that have been
shown to inactivate fosfomycin in several Gram-negative bacterial species.
Among the seven known FosA variants, four (FosA3, FosA4, FosA5, and FosA6) have
been identiﬁed as acquired resistance determinants in E. coli isolates (6–15). The FosA3
variant is the most widespread fosfomycin resistance determinant in E. coli, reported in
human and animal isolates from Asia, Europe, and the United States (6, 7, 16–19). The
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natural reservoir of some plasmid-mediated fosA determinants has been identiﬁed. The
fosA3, fosA5, fosATn2921, and fosA6 genes originate from Kluyvera georgiana, Klebsiella
pneumoniae, Enterobacter cloacae, and Klebsiella pneumoniae, respectively (9, 10).
Recently, by performing a screening of fosfomycin resistance determinants among
a collection of ESBL-producing E. coli isolates from Switzerland, we identiﬁed a single
isolate harboring a plasmid-mediated fosfomycin resistance determinant that did not
correspond to any known fosA gene (20). Therefore, the purpose of the study was to
characterize this fosfomycin resistant determinant and to identify its origin.
RESULTS
Identiﬁcation of the fosA8 gene. E. coli isolate 376 was resistant to broad-spectrum
cephalosporins, ﬂuoroquinolones, kanamycin, tobramycin, and tetracycline (Table 1). It
was also resistant to fosfomycin, according to the result of the rapid fosfomycin NP test
(21), and had a fosfomycin MIC value of 1,024 g/ml. This MIC value was reduced by
16-fold when phosphonoformate (PPF) was added, suggesting the presence of a FosA
group glutathione-S-transferase activity (22). Using whole-cell DNA from E. coli 376 as
the template, PCR ampliﬁcations were negative for the known fosA genes (fosA1 to
fosA7 genes). Whole-genome sequencing (WGS) of E. coli 376 was then performed to
possibly identify the mechanism that is responsible for fosfomycin resistance. A gene
with a signiﬁcant homology to fosA-like genes was identiﬁed. This novel fosA gene,
which was named fosA8, encoded the FosA8 enzyme, which was 141 amino acids long
and shared 66% to 79% amino acid identity with the FosA1 to FosA7 enzymes, the most
closely related being FosA2. A BLAST search revealed that the same fosA8 gene was
present in two E. coli strains isolated in the United States (GenBank accession no.
CP041527.1 and CP019910.1).
Phylogenetic analysis performed with FosA8 and the other FosA type enzymes
revealed that FosA8 was distantly related to the FosA enzymes, representing a distinct
cluster of FosA proteins (Fig. 1). FosA8 possessed conserved residues of FosA proteins
that are implicated in the dimer formation of the FosA proteins, of Mn2 and K
binding, and to fosfomycin binding (1) (Fig. 2).
Genetic context of the fosA8 gene. Analysis of the WGS of E. coli 376 showed that
the fosA8 gene was located on a plasmid that also carried a kanamycin resistance
marker. Mating-out assays showed that this plasmid was self-conjugative, at a fre-
quency that was estimated to be ca. 105. This plasmid did not carry the blaCTX-M-15
ESBL gene that was identiﬁed in E. coli 376. PCR-based replicon typing and plasmid
analysis following extraction by the Kieser method (23) performed with isolate 376
conﬁrmed the WGS data and identiﬁed an IncN natural plasmid 50 kb in size. The fosA8
gene was inserted into the sprT gene and was bracketed by two direct repeat se-
quences (Fig. 3). The sprT gene encoded a hypothetical protein of unknown function
(Fig. 3). The occurrence of identical direct repeats, TATTA, on each side of the DNA
fragment encompassing the fosA8 gene strongly suggested that the insertion of the
fosA8 gene onto its plasmid support resulted from a transposition event (Fig. 3).
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Relevant genotype or phenotype Reference or source
Strains
E. coli
J53 Recipient strain for conjugation experiment; azide resistant 34
TOP10 Recipient strain for cloning experiments Invitrogen
376 Clinical isolate resistant to extended-spectrum cephalosporins,
ﬂuoroquinolones, kanamycin, tobramycin, tetracycline, and fosfomycin
This study
L. adecarboxylata DSMZ5077 Natural fosfomycin-resistant enterobacterial species This study
Plasmids
pACYC184 Cloning plasmid; chloramphenicol and tetracycline resistant New England Biolabs
p376 Natural ca. 50-kb and IncN plasmid of E. coli 376 This study
pFosA8 Recombinant plasmid pACYC184 with a 789-bp PCR fragment (fosA8) This study
pFosALA Recombinant plasmid pACYC184 with a 789-bp PCR fragment (fosALA) This study
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Origin of the fosA8 gene. In silico analysis using the GenBank databases conﬁrmed
that fosA-like genes are present in the chromosomes of several enterobacterial species,
such as those of Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, and
Kluyvera ascorbata (9). FosA8 showed the highest percentage of amino acid identity
(98%, differing in 3 amino acids) with a FosA protein, named FosALA, which is encoded
by a gene identiﬁed in the chromosome of the enterobacterial species Leclercia
adecarboxylata strain USDA-ARS-USMARC-60222 (GenBank accession no. CP013990.1).
Accordingly, the close sequences located upstream and downstream of the fosA8 gene
shared signiﬁcant identity at the nucleotide level (99%) with those of L. adecarboxylata
USDA-ARS-USMARC-60222 (Fig. 3).
FIG 1 Phylogenetic tree obtained for the FosA proteins identiﬁed by distance method using the
neighbor-joining algorithm (SeaView version 4 software [33]). Branch lengths are drawn to scale and are
proportional to the number of amino acid substitutions with 500 bootstrap replications. The distance
along the vertical axis has no signiﬁcance. The enterobacterial species known as the natural reservoirs of
these FosA proteins are shown on the right.
FIG 2 Amino acid alignment of plasmid-mediated FosA proteins. Red, blue, green, and purple boxes
bracket amino acids of the dimer interface loop and those implicated in Mn2 coordination, in the K
binding loop, and in fosfomycin binding, respectively (11).
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Highly similar fosALA-like genes were identiﬁed in six chromosomes of Leclercia
species available in the genome databases, including two L. adecarboxylata isolates
(GenBank accession no. CP036199.1 and LR590464.1) and four Leclercia species isolates
(GenBank accession no. CP026387.1, CP026167.1, CP031104.1 and CP031101.1), sharing
from 85% to 97% nucleotide identity with fosALA.
The enterobacterial species L. adecarboxylata is rarely identiﬁed as a source of
human infections and is naturally resistant to fosfomycin (24, 25).
In order to characterize the fosfomycin resistance conferred by FosLA, the L. adecar-
boxylata strain DSMZ5077 was analyzed. It carried a fosLA gene identical to that of L.
adecarboxylata strain USDA-ARS-USMARC-60222. The fosfomycin resistance phenotype
observed in L. adecarboxylata DSMZ5077 was antagonized by the addition of phos-
phonoformate (with the fosfomycin MIC value being decreased by 16-fold), indicating
the role of FosALA for conferring fosfomycin resistance in that species. Both fosA8 and
fosALA genes were cloned and expressed in E. coli TOP10. They conferred identical levels
of resistance to fosfomycin (fosfomycin MIC, 1,024 mg/liter).
DISCUSSION
We report here the identiﬁcation of a novel plasmid-mediated and transferable
fosfomycin resistance determinant, FosA8, in E. coli. This enzyme conferred a high level
of resistance to fosfomycin. Its 80% amino acid identity with known FosA proteins
indicates the diversity of fosA genes that may circulate, remaining undetected when
screening surveys based on molecular tools are performed. It is noteworthy that
analysis of GenBank databases showed that this gene is present in two E. coli isolates
recovered in the United States, indicating that it is already present on another conti-
nent.
The concomitant identiﬁcation of the natural reservoir of the fosA8 gene, L. decar-
boxylata, adds to the growing list of enterobacterial species that naturally possess a
fosA-like gene and from which those genes are translocated onto plasmids in E. coli (9,
10). In contrast to other enterobacterial species that possess these fosA-like genes, such
as K. pneumoniae (9), fosA8-like genes are likely expressed at a high level in L.
decarboxylata, since this species is naturally resistant to fosfomycin (25) and the
fosfomycin resistance is inhibited by the addition of phosphonormate. The driving
forces at the origin of transfer and the spread of fosA genes from their natural reservoir
to a plasmid location in an enterobacterial species, E. coli, which does not possess a fosA
gene, remain to be investigated.
This novel FosA determinant is reported from an E. coli isolate belonging to
sequence type 40 (ST40) that is recognized as an emerging extraintestinal E. coli clone
(26). Of note, the fosA8 and blaCTX-M-15 genes were not associated on the same plasmid.
This is in contrast to the most commonly identiﬁed fosA gene, fosA3, which is always
identiﬁed on plasmids carrying either ESBL genes, AmpC-type -lactamase genes, or
carbapenemase genes (16–19).
Nonetheless, identiﬁcation of the FosA8 determinant from a CTX-M-producing
FIG 3 Genetic structures surrounding the fosALA gene on the chromosome of L. adecarboxylata (A) and
on the fosA8 gene on plasmid p376 of E. coli 376 (B). The grey-shaded sequences indicate sequence
identity between plasmid p376 and L. adecarboxylata DSMZ5077. TATTA direct repeats bracketing fosA8
on plasmid p376 are also indicated.
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isolate further highlights that ESBL producers are important reservoirs of transferable
fosfomycin resistance determinants. This result may be a source of concern, since
fosfomycin is becoming a ﬁrst-line therapy for treating cystitis due to ESBL producers
and the prevalence of ESBL producers is still rising worldwide.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli isolate 376 was isolated from urine in the context of screening
1,225 ESBL-producing E. coli isolates from a Swiss collection obtained from 2012 and 2013 (20). The list
of strains and plasmids used in the study is shown in Table 1.
Fosfomycin resistance determination. Two techniques were used to assess fosfomycin suscepti-
bility. First, the agar dilution method using cation-adjusted Mueller-Hinton agar (MHA-CA, reference
64884; Bio-Rad, Marnes-la-Coquette, France) supplemented with 25 g/ml glucose-6-phosphate was
used to determine fosfomycin MICs, as recommended by Clinical and Laboratory Standards Institute
(CLSI) guidelines (27). The breakpoints of the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) were used as a reference (28). E. coli isolates with MICs of 32 g/ml were categorized
as resistant. Second, the rapid fosfomycin/E. coli NP test was performed as described by Nordmann et al.
(21). The results of this test were read after 1 h 30 min of incubation at 35 2°C.
FosA-like role in fosfomycin resistance. The contribution of a potential FosA-like enzyme in
fosfomycin resistance was assessed ﬁrst by using the disk diffusion method as described by Nakamura
et al. (22). Brieﬂy, the fosfomycin-resistant E. coli 376 and the L. decarboxylata DBZ isolate at an 0.5
McFarland standard were inoculated onto Mueller-Hinton agar plates supplemented with 25 g/ml of
glucose-6-phosphate. Two disks containing 200 g of fosfomycin, with and without 0.5 mg of the FosA
inhibitor sodium phosphonoformate (PPF) (Sigma-Aldrich), were added to the plates, which were
incubated at 35 2°C overnight. Actually, PPF selectively inhibits the FosA-like proteins, which allows
differentiation between plasmid-mediated FosA and other mechanisms of resistance to fosfomycin. An
increase in the diameter of the growth inhibition zone by 5 mm in the presence of PPF is interpreted
as FosA-related resistance.
Molecular analyses. DNA was extracted from E. coli strain 376 with the QIAamp DNA minikit and the
QIAcube workstation (Qiagen, Courtaboeuf, France), according to the manufacturer’s instructions. PCR
ampliﬁcation (Microsynth, Balgach, Switzerland) was performed to detect any known plasmid-mediated
fosA genes (fosA1 to fosA7), as previously described (21). PCR conditions were 95°C for 5 min, followed
by 30 cycles of 95°C for 30 s, 52°C for 30 s and 72°C for 30 s, with a ﬁnal extension of 72°C for 5 min.
Sequences were analyzed with CloneManager Professional (Sci-Ed Software, Denver, CO, USA) (29).
Whole-genome DNA of the fosA8-positive E. coli isolate and its transconjugant was extracted using a
Sigma-Aldrich GenElute bacterial genomic DNA kit. Genomic libraries were assessed using a Nextera XT
library preparation kit (Illumina Inc., San Diego, CA), and sequencing was performed using an Illumina
MiniSeq system with 300-bp paired-end reads and a coverage of 50 times. The generated FastQ data
were compiled and analyzed using the CLC Genomic Workbench (version 7.5.1; CLC Bio, Aarhus,
Denmark). Reads were de novo assembled with automatic bubble and word size, and contigs with a
minimum contig length of 800 nucleotides were generated using the mapping mode map reads back to
contigs. The resulting contigs were uploaded into the Center for Genomic Epidemiology server (http://
www.genomicepidemiology.org/). The plasmid replicon type and multilocus sequence type according to
the Warwick typing scheme were determined using the PlasmidFinder (version 1.3) and MLST (version
1.8) programs, respectively (26, 30, 31). Sequence alignments was performed with ESPript 3.0 software,
and construction of phylogenetic trees was performed with the SeaView alignment tool (version 4; Prabi,
La Doua, Lyon, France) (32).
The fosA8 gene from E. coli 376 and the fosLA gene from L. adecarboxylata were cloned into the
pACYC184 vector by using primers listed in Table 2 and expressed in E. coli TOP10.
Plasmid analysis and conjugation. Plasmid analysis was performed using the Kieser extraction
method (23), followed by gel electrophoresis, in order to further conﬁrm the size of the plasmid
containing the fosA8 gene using E. coli strain 50192 harboring four plasmids of 154, 66, 48, and 7 kb as
plasmid size markers (33). The determination of the plasmid incompatibility group was conﬁrmed by
PCR-based replicon typing (PBRT) (30). Conjugation experiments were performed using E. coli strain 376
and azide-resistant strain E. coli J53 as donor and recipient strains, respectively, as described previously
(20). Both donor and recipient strains were cultured in exponential phase and then mixed on solid Luria
Broth agar using ﬁlters at a 1:10 donor/recipient ratio. After 5 h of incubation, the ﬁlters were
resuspended in 0.85% NaCl and the bacterial mixture was plated onto agar plates supplemented with
fosfomycin (25 g/ml) and sodium azide (100 g/ml). The susceptibility of all E. coli transconjugants to
TABLE 2 Oligonucleotide sequences designed for this studya
Primer Sequence
fosA8 BamHI forward 5=-GATGATGGATCCAGCGTGAAATGGAAGTGTGG-3=
fosA8 SalI forward 5=-GATGATGTCGACTAATACTGGTGATCCACGGC-3=
fosA8 intern forward 5=-AACCATCTGACCCTTGCTGT-3=
fosA8 intern reverse 5=-CGAGAAAATAGAACGACGCC-3=
aRestriction sites are underlined; intern, internal to the fosA gene.
5
ht
tp
://
do
c.
re
ro
.c
h
fosfomycin was assessed by disk diffusion with azide- and fosfomycin-containing disks and by the PPF
test (22).
Accession number(s). The sequence data corresponding to the fosA8 gene reported in this paper
was submitted to the GenBank nucleotide database under accession no. MN150127. In addition, the
contigs corresponding to the whole genome of isolate 376 have been deposited as a BioProject under
accession no. PRJNA558667.
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